REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease

Abroad (travel likely)Recruiting

Conditions

Coronary Heart Disease (CHD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Zhongshan Hospital, Shanghai, China
Contact: Study coordinator (Chunfeng Dai, M.D.) · dai.chunfeng@zs-hospital.sh.cn · 86-021-64041990
Contact: Principal Investigator (Chunfeng Dai, M.D.)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I)

Coronary Heart Disease (CHD)

Abroad (travel likely)Recruiting

Beijing, China · Haikou, China

Closed-Loop Neurofeedback Targeting the Right Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety

Coronary Heart Disease (CHD) · Anxiety Disorders

Abroad (travel likely)Recruiting

Shenyang, China

AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study

Coronary Heart Disease (CHD)

Abroad (travel likely)Recruiting

Beijing, China

Clinical Outcomes of Patients With Coronary Artery Disease

Coronary Heart Disease (CHD)

Abroad (travel likely)Recruiting

Shenyang, China